Crispr-Based Replacement of The Endogenous T-Cell Repertoire With Novel, High-Avidity, Natural T Cell Receptors To WT1 For The Treatment of Acute Myeloid Leukemia
BONE MARROW TRANSPLANTATION(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined